Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Nasal Spray Vaccines Get CEPI, NIH Funding

Nasal spray

A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea. . . . → Read More: Nasal Spray Vaccines Get CEPI, NIH Funding

Univ. Labs Ink Licensing Deals for Covid-19 Tests

Home testing station

Two companies agreed to license technologies from academic labs in the U.S. and U.K. for developing faster and more sensitive at-home tests for Covid-19 infections. . . . → Read More: Univ. Labs Ink Licensing Deals for Covid-19 Tests

Infographic – Fewer in US See Covid-19 Threat

Chart: Views of Covid-19 threat

The percentage of Americans viewing Covid-19 as a major threat to public health is declining, with a majority now saying the disease is a minor or no threat at all. . . . → Read More: Infographic – Fewer in US See Covid-19 Threat

Trial Shows Oral Covid-19 Vaccine Produces Antibodies

White pills

A clinical trial shows a Covid-19 vaccine taken as a tablet produces protective antibodies in nasal membranes that in some cases last for up to a year. . . . → Read More: Trial Shows Oral Covid-19 Vaccine Produces Antibodies

CEPI Funds New Broad Coronavirus Vaccine

Exosome illustration

An international health group is funding a new vaccine to cover a broad range of coronaviruses using exosomes, tiny natural bubbles for delivery to cells. . . . → Read More: CEPI Funds New Broad Coronavirus Vaccine

Infographic – Cyberattacks Rated Top Global Threat

U.S. global threats 2022

Large majorities of Americans now consider cyberattacks and disinformation online as their main worldwide threats, according to a recent poll. . . . → Read More: Infographic – Cyberattacks Rated Top Global Threat

Infographic – US Workers Returning to Work

Chart: Work from home percentage

New data from the U.S. Bureau of Labor Statistics, displayed in chart form last week, indicate the work-from-home era may be closing. . . . → Read More: Infographic – US Workers Returning to Work

AI Drug Company Creating Covid-19 Therapy for Rapid Delivery

Global Covid-19

A company applying artificial intelligence to drug discovery says it designed a new oral drug for Covid-19 infections that can be quickly produced. . . . → Read More: AI Drug Company Creating Covid-19 Therapy for Rapid Delivery

Partnership Developing Faster, Sensitive Covid-19 Test

SARS-CoV-2 and cell

A collaboration between developers of protein analytics and test-strip diagnostics aims to create a quicker, more sensitive, easy-to-use Covid-19 detection test. . . . → Read More: Partnership Developing Faster, Sensitive Covid-19 Test

Preclinical Tests Show Antibody Stops Covid-19 Variants

Human B-cell

Lab studies show an experimental synthetic antibody protects animals and neutralizes all SARS-CoV-2 variants of concern, including omicron BA.2. . . . → Read More: Preclinical Tests Show Antibody Stops Covid-19 Variants